<DOC>
	<DOCNO>NCT02208271</DOCNO>
	<brief_summary>The purpose study develop biomarker assay use diagnostic tool adverse local tissue reaction , tissue necrosis , metal metal total hip replacement . A convenience sample total 100 hip patient enrol : 50 metal-on-metal revision hip , 25 metal-on-poly revision hip , 25 pre-operative total hip ( implant , control group ) enrol . Preoperative blood serum sample intraoperative synovial fluid obtain hip use biomarker test . Additionally , intraoperative assessment tissue necrosis assess .</brief_summary>
	<brief_title>A Validated Necrosis Assay Determine Need Revision Surgery Metal-on-metal Total Hip Arthroplasty</brief_title>
	<detailed_description>Well-functioning MoM implant show increase serum cobalt chromium ( CoCr ) ion level metal debris generate implant wear.However , current evidence suggest measure ion level unreliable increase ion level correlate tissue damage . In addition measure blood synovial fluid metal ion level , ultrasound MRI metal artifact reduction sequence ( MARS ) utilize assess periarticular reaction secondary metal wear debris . Despite metal reduction software scan frequently difficult interpret . While test merit , present time single diagnostic test available delineates key issue demand urgent surgical intervention , i.e . tissue necrosis . It important reliable test guide surgeon patient share decision-making process surgical intervention necessary prevent disable tissue damage . For reason , current study propose examination preoperative serum sample subject addition synovial fluid collect revision surgery biomarkers may indicate tissue necrosis . To maximize chance success identify serum biomarkers , sample analyze use multianalyte assay , biomarker test . The purpose study develop biomarker assay use diagnostic tool adverse local tissue reaction , tissue necrosis , metal metal total hip replacement . A convenience sample total 100 hip patient enrol : 50 metal-on-metal revision hip , 25 metal-on-poly revision hip , 25 pre-operative total hip ( implant , control group ) enrol . Preoperative blood serum sample intraoperative synovial fluid obtain hip use biomarker test . Additionally , intraoperative assessment tissue necrosis assess .</detailed_description>
	<mesh_term>Necrosis</mesh_term>
	<criteria>Patients present metal metal hip revision cobalt chromium metal ion level test within 6 month date plan revision surgery . Patients present metal poly hip revision Revision hip patient must great one year postoperative The diagnosis time index , primary , hip replacement osteoarthritis . Patients hip osteoarthritis total hip surgery ( control ) Patients present metal metal hip revision cobalt chromium metal ion level test &gt; 6 month date plan revision Patients total hip contralateral side . Patients prior history periprosthetic infection Revision case diagnosis time index , primary , hip replacement osteoarthritis . Prisoners Patients willing consent propose treatment Patients alter mental status Active , concurrent metastatic infection Active , superficial infection Patients present metal poly hip revision treat trunionosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>tissue necrosis</keyword>
	<keyword>metal metal total hip</keyword>
	<keyword>biomarker</keyword>
</DOC>